Anaplastic thyroid cancer overview

Revision as of 07:43, 30 November 2015 by Ammu Susheela (talk | contribs)
Jump to navigation Jump to search

Anaplastic thyroid cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Anaplastic thyroid cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Anaplastic thyroid cancer overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Anaplastic thyroid cancer overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Anaplastic thyroid cancer overview

CDC on Anaplastic thyroid cancer overview

Anaplastic thyroid cancer overview in the news

Blogs on Anaplastic thyroid cancer overview

Directions to Hospitals Treating Anaplastic thyroid cancer

Risk calculators and risk factors for Anaplastic thyroid cancer overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Overview

Historical Perspective

In 1811, the first thyroid cancer case was reported. Thyroid cancer was first described by William Stewart Halsted, an American surgeon in the late nineteenth century.

Pathophysiology

Anaplastic thyroid cancer arises from cells of thyroid, which are secretory cells that are normally involved in production and secretion of thyroid hormones, thyroxine (T4) and triiodothyronine (T3) and is always considered as stage IV. Genes involved in the pathogenesis of follicular thyroid cancer include P53 and BRAF.

Causes

  • Genetic mutation is suspected to be the main cause of anaplastic thyroid cancer.

Differential Diagnosis

Anaplastic thyroid cancer must be differentiated from other diseases that cause neck masses such as goiter, Grave's disease, Hurthle cell carcinoma, follicular thyroid cancer, papillary thyroid carcinoma, follicular adenoma, sarcoma, and medullary thyroid carcinoma.[1]

Epidemiology and Demographics

Females are more commonly affected with follicular thyroid cancer than males. The incidence of follicular thyroid cancer increases with age; the median age at diagnosis is 6th to 7th decades.

Risk Factors

Common risk factors in the development of anaplastic thyroid cancer are iodine deficiency, family history of thyroid cancer, and radiation exposure.

Natural history, Complications and Prognosis

Depending on the extent of the tumor at the time of diagnosis, the prognosis of anaplastic thyroid cancer may vary. However, the prognosis is generally regarded as poor. The presence of metastasis is associated with a particularly poor prognosis among patients with anaplastic thyroid cancer.

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Chest x-ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Biopsy

Medical Therapy

Surgery

Prevention

Effective measures for the prevention of anaplastic thyroid cancer include avoidance of diets low in iodine and avoidance of ultraviolet exposure.

Reference

  1. Thyroid Cancer Cancer.gov (2015). http://www.cancer.gov/types/thyroid/hp/thyroid-treatment-pdq#section/_6- Accessed on October, 29 2015